跳至主要内容
临床试验/NCT00707603
NCT00707603已完成不适用

Understanding the Relationship Between Insulin Resistance and Chronic Hepatitis C Infection

Garvan Institute of Medical Research2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2006年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Insulin Resistance by euglycaemic hyperinsulinaemic clamp Liver fat, abdominal fat and muscle fat measures

研究概览

简要总结

Chronic hepatitis C (CHC) is among the commonest chronic infectious disease in Australia with >200,000 exposed persons. Amongst non-infectious chronic conditions- Type 2 diabetes, obesity and heart disease are extremely common. This study will examine the relationship between insulin resistance, fat deposition in the liver, muscle and abdomen, and liver injury due to CHC

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Caucasian male
  • Age: 25-55 years
  • Chronic Hepatitis C (PCR positive) and fibrosis ≤ F2 (if liver biopsy done)
  • Genotypes 1 or 3
  • Due to commence antiviral therapy
  • BMI < 30

排除标准

  • Cirrhosis or F3 fibrosis on liver biopsy (if done)
  • > 20 g ETOH per day
  • Type 2 Diabetes (need an OGTT if fasting BGL> 5.7)
  • Concurrent HIV
  • Other cause of liver disease

结局指标

主要结局

Insulin Resistance by euglycaemic hyperinsulinaemic clamp Liver fat, abdominal fat and muscle fat measures

时间窗: 2 years

次要结局

  • insulin resistance post treatment of Hep C(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Jerry Greenfield

Head of Endocrinology Department St Vincent's Hospital Sydney

Garvan Institute of Medical Research

研究点 (2)

Loading locations...

相似试验

Chronic Hepatitis C and Insulin Resistance | 临床试验